Photo Rounds

Vesicular eruption in a 2-year-old boy

Author and Disclosure Information

 

References

Antivirals and antibiotics should be given until lesions heal

Patients with EH should be admitted to the hospital for at least 24 to 48 hours of intravenous acyclovir.4 Antivirals—oral or intravenous—should be given for 10 to 14 days or until all mucocutaneous lesions are healed. Recommended dosing for acyclovir is 15 mg/kg (up to 400 mg) by mouth 3 to 5 times per day or, if severe, 5 mg/kg (if ≥12 years of age) to 10 mg/kg (if <12 years of age) intravenously every 8 hours.2 Patients should also receive a 3- to 6-month suppressive course of oral acyclovir, valacyclovir, or famciclovir.4

Intravenous antibiotics should also be considered, pending the results of bacterial skin swabs and a blood culture, as the skin of patients with atopic dermatitis is colonized with staphylococcus 90% of the time.4

Potential complications. Bacterial sepsis resulting from superinfection and disseminated HSV, although extremely rare, is the main cause of death associated with EH.3 One case in the literature described a 43-year-old woman with extensive EH superimposed on atopic dermatitis, disseminated HSV, and Pseudomonas aeruginosa septicemia. Despite treatment with intravenous acyclovir and antibiotics in a burn center intensive care unit, the patient experienced septic shock and disseminated intravascular coagulation with progression to multiorgan failure and death.3

Our patient’s antiviral regimen was transitioned to a 14-day course of oral acyclovir, which he completed. Topical steroids and an immunosuppressant (tacrolimus ointment) were applied concurrently. He was subsequently prescribed a 6-month suppressive course of acyclovir and was scheduled for follow-up at an outpatient dermatology clinic to discuss resuming therapy for atopic dermatitis.

CORRESPONDENCE
Sahand Rahnama-Moghadam, MD, 7323 Snowden Road #1205, San Antonio, TX 78240; rahnamamogha@uthscsa.edu.

Pages

Recommended Reading

Growths on neck and beard area
MDedge Family Medicine
VIDEO: Smart insole system helped reduce reulceration risk
MDedge Family Medicine
Full resolution of psoriasis in half of ixekizumab patients
MDedge Family Medicine
Updated Behçet’s disease recommendations expand biologic treatment
MDedge Family Medicine
ACIP hints at move from three-dose to two-dose HPV vaccination schedule for youth
MDedge Family Medicine
Obesity may attenuate anti-TNF response in psoriatic arthritis
MDedge Family Medicine
Clinical Guidelines: Update in acne treatment
MDedge Family Medicine
Clinical Guidelines: Update in acne treatment
MDedge Family Medicine
Blisters on toes
MDedge Family Medicine
Generalized rash follows ankle ulceration
MDedge Family Medicine